---
$id: https://graph.org.ai/products/commodity/51161563
$type: Product
source: UNSPSC
code: "51161563"
title: "Zafirlukast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Zafirlukast

**UNSPSC Code**: 51161563
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C31H33N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XZ629S5L50, chemically known as ici 204,219 but generally known as zafirlukast, which bears US NIH Compound Identifier 5717. European Medicines Agency schedules Zafirlukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00128MIG. The term ZAFIRLUKAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules zafirlukast in its Anatomical Therapeutic Chemical (ATC) Classification. ZAFIRLUKAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zafirlukast under HS 29350090 and SITC 51580. As of Q4 2014, ZAFIRLUKAST remains the US FDA Preferred Term for this commodity. Zafirlukast bears US NLM identifiers UMLS ID C0378466 and NCI Concept Code C47785. SMILES: S(=O)(=O)(NC(=O)C1CC(OC)C(CC2C3C(N(C2)C)CCC(NC(=O)OC2CCCC2)C3)CC1)C1C(CCCC1)C.

